Potent immunomodulation and angiogenic effects of mesenchymal stem cells versus cardiomyocytes derived from pluripotent stem cells for treatment of heart failure

BACKGROUND: Optimal cell type as cell-based therapies for heart failure (HF) remains unclear. We sought to compare the safety and efficacy of direct intramyocardial transplantation of human embryonic stem cell-derived cardiomyocytes (hESC-CMs) and human induced pluripotent stem cell-derived mesenchy...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Songyan, Zhang, Yuelin, Ting, Sherwin, Zhen, Zhe, Luo, Fan, Zhu, Ziyi, Jiang, Yu, Sun, Sijia, Lai, Wing-Hon, Lian, Qizhou, Tse, Hung-Fat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407247/
https://www.ncbi.nlm.nih.gov/pubmed/30845990
http://dx.doi.org/10.1186/s13287-019-1183-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407247/
https://www.ncbi.nlm.nih.gov/pubmed/30845990
http://dx.doi.org/10.1186/s13287-019-1183-3

Ejemplares similares